Variability in Institutional Review Board Assessment of Minimal‐risk Research

Abstract

Objectives:To examine variability in responses from institutional review boards (IRBs) to submission of a proposed minimal-risk survey. Methods: Identical research proposals to obtain information concerning beliefs about the needs of victims of intimate partner violence via surveys were submitted for IRB approval to three institutions in the Baltimore metropolitan area. One institution is an academic center, one is an inner-city hospital affiliated with the academic center, and the third is a suburban community hospital.

Reactions to Participating in Dating Violence Research: Are Our Questions Distressing Participants?

“…Indeed, Newman and Kaloupek (2004) stated "It is likely that a nearly universal concern of IRBs is the potential for emotional harm due to recall of traumatic events" (p. 390). IRBs are designed to ensure the protection and ethical treatment of research participants (Hirshon et al, 2002), and this is especially important for vulnerable populations such as victims of violence (Logan, Walker, Shannon, & Cole, 2008). However, IRBs have historically had to make decisions on the ethics of research proposals and protection of human subjects based on personal opinions and subjective data, as there is often a lack of scientific, objective research on the risks and benefits of trauma-related research (Carter-Visscher, Naugle, Bell, & Suvak, 2007).…”

Considerations for Diabetes Translational Research in Real-World Settings

“…Attempts at change on the part of any one of the key players impacting diabetes translational efforts without support from the others will fail (9). In addition, it is vital that institutional review boards safeguard potential and actual research subjects while maintaining the public's access to studies they might wish to participate in (9,44,45).…”

Revisão ética e termo de consentimento livre e esclarecido nas publicações de pesquisas cardiovasculares na Argentina

“…Finally, 10 articles (2.9%) were typical clinical trials of pharmacology or cellular therapy. Table 1 resumes recommendations for IRB evaluation, informed consent and local federal regulations requirements for each type of article [9][10][11][12][13][14] .…”